Skeletal Muscle of Patients with Duchenne's Muscular Dystrophy: Evidence of a Mitochondrial Proteolytic Factor Responsible for Calmitine Deficiency

By Lucas-Heron B.  

Biochemical and Biophysical Research Communications, Vol. 223, Iss. 1, 1996-06 ,pp. : 31-35

Elsevier

Access to resources Recommend Favorite

Absence of a Calmitine-Specific Protease Inhibitor in Skeletal Muscle Mitochondria of Patients with Duchenne's Muscular Dystrophy

By Lucas-Heron B.  

Biochemical and Biophysical Research Communications, Vol. 225, Iss. 3, 1996-08 ,pp. : 701-704

Elsevier

Access to resources Recommend Favorite

Active and inactive ecto-5'-nucleotidase variants in liver of control and dystrophic Lama2dy mice

By Morote-Garcia J.C.   Garcia-Ayllon M.S.   Campoy F.J.   Vidal C.J.   Munoz-Delgado E.  

The International Journal of Biochemistry and Cell Biology, Vol. 36, Iss. 3, 2004-03 ,pp. : 422-433

Elsevier

Access to resources Recommend Favorite

Targeted Disruption of Exon 52 in the Mouse Dystrophin Gene Induced Muscle Degeneration Similar to That Observed in Duchenne Muscular Dystrophy

By Araki E.   Nakamura K.   Nakao K.   Kameya S.   Kobayashi O.   Nonaka I.   Kobayashi T.   Katsuki M.  

Biochemical and Biophysical Research Communications, Vol. 238, Iss. 2, 1997-09 ,pp. : 492-497

Elsevier

Access to resources Recommend Favorite

Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy

By Yokota Toshifumi   Pistilli Emidio   Duddy William   Nagaraju Kanneboyina  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 6, 2007-06 ,pp. : 831-842

Informa Healthcare

Access to resources Recommend Favorite